StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3056% above fair value
$30.52+0.57 (+1.90%)

Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%

Pfizer All Other Specialty Care by Year

All Other Specialty Care — International revenues ($M) ($M)

Pfizer All Other Specialty Care: $874M in FY2025, up 18.8% from a year earlier.

Latest, FY2025
874
Period ended Dec 31, 2025
Change on a year earlier
+18.8%
736 in FY2024
History
5 years
Since FY2021
Sources
4
Documents cited below

Where the FY2025 figure comes from

“|| All other Specialty Care | 1,588 | 1,489 | 7% | 7% | 715 | 753 | (5%) | 874 | 736 | 19% | 20%”

Source: Form 8-K (Earnings / Guidance Release) (pfe-12312025xex99.htm, filed 2026-02-03) ↗

Reported in Form 8-K Revenue Tables & Form 10-Q / 10-K Segment Footnotes.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Breakdown

What makes up all Other Specialty Care

Cite this data

StockData. (2026). Pfizer All Other Specialty Care ($M), annual FY2021–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/other-sc-intl

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.